Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Aug 04, 2022
Thursday Aug 04, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading lung cancer experts share their perspectives on recent advances in the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and how they are changing clinical practice.
The experts
- Dr Marina Garassino - University of Chicago, Chicago, IL, USA
- Dr Louis Paz-Ares - Hospital Universitario 12 de Octubre, Complutense University and Ciberonc, Madrid, Spain
- DR Martin Edelman - Fox Chase Cancer Center, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/ES-SCLC-first-line-treatment
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.